| Literature DB >> 33619081 |
Netta Barak1, Roni Ben-Ami2,3, Tal Sido3,4, Amir Perri5, Aviad Shtoyer5, Mila Rivkin3, Tamar Licht6, Ayelet Peretz2, Judith Magenheim2, Irit Fogel3, Ayalah Livneh3, Yutti Daitch3, Esther Oiknine-Djian3, Gil Benedek3,7, Yuval Dor8, Dana G Wolf9,10, Moran Yassour11,12.
Abstract
Pooling multiple swab samples before RNA extraction and real-time reverse transcription polymerase chain reaction (RT-PCR) analysis has been proposed as a strategy to reduce costs and increase throughput of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests. However, reports on practical large-scale group testing for SARS-CoV-2 have been scant. Key open questions concern reduced sensitivity due to sample dilution, the rate of false positives, the actual efficiency (number of tests saved by pooling), and the impact of infection rate in the population on assay performance. Here, we report an analysis of 133,816 samples collected between April and September 2020 and tested by Dorfman pooling for the presence of SARS-CoV-2. We spared 76% of RNA extraction and RT-PCR tests, despite the frequently changing prevalence (0.5 to 6%). We observed pooling efficiency and sensitivity that exceeded theoretical predictions, which resulted from the nonrandom distribution of positive samples in pools. Overall, our findings support the use of pooling for efficient large-scale SARS-CoV-2 testing.Entities:
Year: 2021 PMID: 33619081 DOI: 10.1126/scitranslmed.abf2823
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956